FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to endocrinology, and can be used to predict the risk of type 2 diabetes development. Clinical and medical history: BWI, WC, AH, diabetes of close relatives. Laboratory data are determined: TG, HDLPC, readings of systolic and diastolic, blood sugar levels. Evaluation of the obtained data in points and totalizing. When the total is less than 8 points, a low degree of risk of type 2 diabetes is predicted for the next 10 years. When the total is greater than or equal to 8 points, a high degree of risk of type 2 diabetes development is predicted.
EFFECT: prediction method, which allowing the most accurate determination of the risk of type 2 diabetes development for the next 10 years based on assessment of the most significant indicators.
2 dwg, 6 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTING THE RISK OF DEVELOPING TYPE 2 DIABETES MELLITUS IN OBESE AND/OR PRE-DIABETIC INDIVIDUALS | 2022 |
|
RU2801174C1 |
| METHOD OF SELECTING MEN AT PRE-DIABETES RISK GROUP AND TYPE 2 DIABETES MELLITUS | 2017 |
|
RU2695322C2 |
| METHOD FOR PREDICTING CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH LOW OR MODERATE CARDIOVASCULAR RISK BY ASSESSING THEIR PSYCHOLOGICAL STATUS | 2020 |
|
RU2750716C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING TYPE 2 DIABETES IN RESIDENTS OF CENTRAL RUSSIA BASED ON GENOTYPING OF THE rs11073891 POLYMORPHISM OF THE ANPEP GENE | 2023 |
|
RU2803636C1 |
| METHOD FOR COMPLEX ASSESSMENT OF CARDIOVASCULAR RISK WITH DETERMINATION OF TARGET LEVELS OF LOW-DENSITY LIPOPROTEIN CHOLESTEROL AND CORRECTION OF LIPID-LOWERING THERAPY | 2020 |
|
RU2746835C1 |
| CALCULATION OF INDIVIDUAL RISK OF TYPE 2 DIABETES IN PATIENTS WITH GOUT | 2022 |
|
RU2798778C1 |
| METHOD FOR MONITORING INDIVIDUALS WITH RISK OF EARLY ATHEROSCLEROSIS AND SUFFERING FROM TYPE 2 DIABETES MELLITUS | 2013 |
|
RU2533836C1 |
| METHOD OF INCREASING COMMITMENT TO HYPOLIPIDEMIC THERAPY | 2011 |
|
RU2470579C1 |
| METHOD FOR DETERMINING INDIVIDUAL PROFILE OF TOTAL CARDIOVASCULAR RISK FACTORS IN PATIENT OF WORKING AGE | 2021 |
|
RU2757752C1 |
| METHOD OF BIOIMPEDANCE DETECTION OF METABOLIC SYNDROME AND TYPE 2 DIABETES MELLITUS PREDICTOR IN YOUNG PEOPLE WITH NORMAL BODY WEIGHT | 2009 |
|
RU2408261C1 |
